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Fat mass and obesity-associated (FTO) gene variants are associated with childhood and adult obesity; however, the influence of FTO
polymorphisms on foetal growth is unknown. Associations between the FTO variant rs9939609 and the foetal growth trajectories, maternal
pregnancy weight gain, anthropometric measures at birth and body mass index (BMI) at age 14 years were assessed in 1079 singleton-birth
Australian Caucasians. Analyses were repeated in 3512 singleton-birth Dutch Caucasians. The rs9939609 obesity-risk AA genotype was
associated with symmetrical intrauterine growth restriction; an effect reversed in mothers who smoked during pregnancy. The effect increased
over time and was modified by maternal smoking for head circumference (P5 0.007), abdominal circumference (P5 0.007), femur length
(P5 0.02) and estimated foetal weight (P5 0.001). The modification of the association between the AA genotype and birth anthropometrics
by maternal smoking was consistent across birth weight (P5 0.01) and birth length (P5 0.04) and neonatal day 2 anthropometry. Consistent
associations were replicated in the Generation R cohort. Maternal pregnancy weight gain matched the pattern of birth weight and was
independent of placental weight. In adolescents, the AA genotype was associated with increased BMI-adjusted-for-age in males (P5 0.00009),
but no effect was detected in females. A variant in the FTO gene influences foetal growth trajectories in the third trimester, early postnatal
growth and adiposity in adolescence. Maternal smoking during pregnancy reversed the direction of association of rs9939609 on foetal growth,
which was probably mediated by maternal energy intake. The detection of genetic variants associated with foetal growth has the potential to
identify novel molecular mechanisms underlying growth and targeted early life intervention.
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Background
Obesity is a major public health problem, with at least 20
million overweight children under the age of 5 years and 1.6
billion overweight adults globally in 2005.1 Although obesity
has traditionally been considered a problem of high-income
countries, it is now being recorded at increased levels across
high-, middle- and low-income countries.2
Obesity increases the risk of coronary heart disease, the
metabolic syndrome, some cancers, stroke, liver and gallbladder
disease, sleep apnoea and respiratory problems, osteoarthritis
and gynaecological problems.3 Intervention programmes have
traditionally targeted the individual at the onset of disease-
precursors; however, the principles underlying the Develop-
mental Origins of Health and Disease suggest that there may be
critical windows earlier in the developmental continuum
(including pregnancy, infancy and childhood) that may offer
greater opportunities for obesity prevention.4,5
The discovery of the fat mass and obesity-associated (FTO)
gene is a notable success story from the recent explosion in
knowledge resulting from genome-wide association studies
(GWAS). In 2007, Frayling et al.6 identified a common
variant in the FTO gene (rs9939609) that predisposes to
diabetes through an effect on body mass index (BMI). The
results were initially replicated in 13 cohorts with 38,759
participants and further replicated by Dina et al.7 and Scuteri
et al.8 Since these initial reports, there have been eight published
GWAS replicating the association of FTO and obesity, utilising
more than 178,144 samples with replication in a further
193,437 samples.9 Adults of European-descent homozygous
for the minor (A) allele of rs9939609, the most consistently
and strongly associated FTO single nucleotide polymorphism
(SNP), weigh on average 3–4 kg more, and have a 1.67-fold
increase in the odds of obesity compared with those not
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inheriting a risk allele.10 The population-attributable risks for
FTO have been estimated for overweight and obesity in
European populations to be 13% and 20%, respectively.10
FTO variants have been reported to be associated with BMI
from age 76,10–12 years to late adult life.6–8,13 One small study
of 2-week neonates suggested a role for FTO in early stages of
fat accretion in humans;14 however, previous studies have
failed to detect an association between FTO and birth
weight,6 and the association of FTO gene variants with foetal
growth is unknown. However, foetal growth is strongly
associated with the maternal environment and complications
of pregnancy such as diabetes, hypertension and anaemia, in
addition to lifestyle choices such as alcohol intake and smoking
status, have the potential to mask smaller genetic associations.
The primary aim of this study was to investigate the
gene3 environment interaction between the rs9939609 SNP
and maternal smoking with foetal growth in the Western
Australian Pregnancy (Raine) cohort.15 Replication analyses
were performed in the Generation R Pregnancy cohort.16,17
Methods
Western australian pregnancy (Raine) cohort
Recruitment of the Western Australian Pregnancy (Raine) cohort
has previously been described in detail.15,18,19 In brief, between
1989 and 1991, 2900 pregnant women were recruited before
18-week gestation into a randomised controlled trial to evaluate
the effects of repeated ultrasound in pregnancy. Recruitment
predominantly took place at the King Edward Memorial
Hospital (Perth, Western Australia). Women were randomised
to repeat ultrasound measurements at 18, 24, 28, 34 and 38
weeks of gestation or to a single routine ultrasound assessment at
18 weeks. Children have been comprehensively phenotyped
from birth to 18 years of age by trained members of the Raine
research team. DNA was collected at the year-14 follow-up, in
addition to data on dietary intake from food frequency ques-
tionnaire and frequency and duration of exercise undertaken
outside school hours. Month and year of the first menstrual
period for girls were recorded. The study was conducted with
appropriate institutional ethics approval, and written informed
consent was obtained from all the participants. The cohort has
been shown to be representative of the population presenting to
the antenatal tertiary referral centre in Western Australia.15
Generation R cohort
Recruitment of the Generation R cohort has previously been
described in detail.16,17,20,21 In brief, following the local
ethics board’s approval, 9778 mothers with a delivery date
between April 2002 and January 2006 were recruited from
two hospitals, eight midwifery practices and 16 child health
centres in Rotterdam (the Netherlands) to identify early
environmental and genetic causes of normal and abnormal
growth, development and health. The study was conducted
with appropriate institutional ethics approval, and written
informed consent was obtained from all participants. Repeat
ultrasound measurements were made at 12, 20 and 30 weeks
of gestation. Children have been assessed up to 4 years of age
at routine child health centres, and thereafter at two research
centres. The cohort has been shown to be representative of
the antenatal population in Rotterdam.17
Ultrasound assessment in both cohorts
In both cohorts, gestational age (GA) was based on the date of
the last menstrual period unless there was discordance with
ultrasound biometry at the dating scan.17,19 Maternal and
paternal characteristics and breast-feeding duration were self-
reported by questionnaire. Research midwives recorded con-
current maternal medical conditions during pregnancy.
Ultrasound biometry including foetal head circumference
(HC), abdominal circumference (AC), femur length (FL) and
umbilico-placental and utero-placental Doppler flow velocity
waveforms were measured in triplicate using standard tech-
niques. Estimated foetal weight (EFW) was calculated based
on the formula by Hadlock et al.22 Umbilico-placental
function was assessed by a single obstetrician and classed as
‘normal’ (systolic/diastolic ratio less than 95th percentile for
GA) or ‘impaired’ (systolic/diastolic ratio greater than 95th
percentile or absent or reverse end diastolic flow).
Genotyping
DNA was extracted from 5ml samples of EDTA-antic-
oagulated blood using a Puregene DNA isolation kit based on
a simple salting out technique.23 The rs9939609 SNP was
genotyped using the tetra-primer Amplification Refractory
Mutation System (ARMS) polymerase chain reaction (PCR).
PCR reactions for rs9939609 were carried out in a total
volume of 20ml, containing 20 ng of template DNA, a final
concentration of 0.4 pmol of both primers, 200mM dNTP,
3.0mM MgCl2 and 0.4U AmpliTaq Gold
R DNA Poly-
merase. All reactions were incubated for 10min at 958C,
followed by 35 cycles of 45 s denaturation (958C), 1min
annealing (608C) and 1min extension (728C) and an addi-
tional 7min extension at 728C at the end of the 35 cycles.
Statistical analysis
Linear mixed effects models24 were used for the longitudinal
analysis of ultrasound biometry, including intercept and GA
as random effects. Sex and maternal smoking were included
as binary covariates. The rs9939609 genotype was included
as a categorical covariate (TT5 0, TA5 1, AA5 2) and
analysed under a codominant model. Consistent with
previous statistical research in the Raine cohort,25 ultrasound
measurements were power transformed (HC0.5, AC0.4, FL0.7,
log10EFW) before the analysis to ensure homoscedastic
residuals. P-values and 95% confidence intervals were calcu-
lated using the Monte Carlo Markov Chain methods
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(100,000 simulations), which is conservative compared with
the likelihood ratio test.
Cross-sectional analyses of birth anthropometrics, percen-
tage change in weight (loge transformed) and height from
birth to 1 year of age, in addition to BMI at age 14 years
stratified by sex and maternal pregnancy weight gain between
gestation weeks 16 and 34 in the Raine cohort alone, were
performed using multivariate linear regression.
All continuous covariates were mean-centered to minimise
potential correlations between model coefficients. Parity and
breast-feeding duration were coded as ordered categorical
variables. Covariates were selected for multivariate models
using both forwards and backwards stepwise procedures.
Potential covariates included: maternal and paternal age,
height, weight and BMI; maternal smoking indicator (at any
time during the pregnancy); socioeconomic status; mother’s
parity; placental weight and function; GA at birth and sex.
Dietary intake, exercise and puberty variables were included
in the BMI analysis at 14 years of age.
All analyses were performed using the statistical graphics
software R version 2.6.2.26 No corrections were made for
multiple testing because of the highly correlated nature of the
outcome measurements. Clinical relevance was determined by
consistency of effect size and direction.
Results
Analyses were based on 1079 Raine and 3512 Generation R
children who met the criteria of Caucasian, unrelated, sin-
gleton birth, with no congenital disorders and available FTO
genotype. The minor allele frequencies for rs9939609 in the
Raine (A5 0.39) and Generation R (A5 0.39) cohorts were
similar to those quoted in HapMap27 (CEU: A5 0.45).
Table 1 demonstrates the similarity in the distribution of
obstetric, maternal and paternal characteristics across rs9939609
genotypes in both cohorts. No clinically important differences
were seen between the cohorts, with the exception of maternal
smoking and small differences in maternal and paternal age.
Both the proportion of mothers smoking and the quantity of
cigarettes consumed during pregnancy were lower in the con-
temporary Generation R cohort. Non-smoking mothers were
on average slightly higher educated with higher socioeconomic
status. For the index pregnancy, the Generation R parents were,
on average, 3 years older than the parents in the Raine cohort.
Placental weight was not associated with rs9939609 genotype;
however, placental weights were reduced in smoking mothers
(P5 0.04). In the Raine cohort, the average (standard devia-
tion) placental weight was 600 g (126 g) in non-smoking
mothers and 582g (123 g) in smoking mothers.
Foetal growth trajectories
Figure 1a graphically presents the results of the longitudinal
analyses of AC in the Raine cohort. Similar analyses for HC,
FL and EFW are shown in the Supplementary Appendix.
There was no evidence of any difference in the growth tra-
jectories between foetal gender and rs9939609 genotype up to
28-week gestation. Consistent with this finding, in the
Generation R cohort there was no significant association
between rs9939609 genotype and foetal growth up to the
final antenatal ultrasound measurement at 30-week gestation;
AC (P5 0.34), HC (P5 0.87) and FL (P5 0.71). However,
after 28-week gestation, the rs9939609 AA genotype was
associated with foetal growth restriction in non-smoking
Raine mothers, an association, which was reversed in mothers
who smoked during pregnancy. The estimated effect, although
small, accumulated over time and was modified consistently by
maternal smoking for AC (P5 0.007), HC (P5 0.007), FL
(P5 0.017) and EFW (P5 0.001; displayed in Supplementary
Appendix). No association was detected between the rs9939609
AA genotype and the ratio HC/AC, suggesting that the growth
restriction was symmetric. Similar, but smaller, effects were
observed for the rs9939609 TA genotype, indicating that this
association may be a dose–response relationship and dependent
upon the number of A obesity-risk alleles of the foetus.
Birth anthropometry
Table 2 and Fig. 1b display the abridged results of the cross-
sectional analysis of birth weight in the Raine and Generation
R cohorts. All Raine birth anthropometric results, with the
exception of ponderal index, demonstrated a consistent asso-
ciation with the rs9939609 AA genotype, which was modified
by maternal smoking during pregnancy. The AA genotype was
associated with smaller stature and smaller skinfold thickness in
infants from non-smoking mothers; however, this relationship
was reversed in infants from smoking mothers. The analysis of
measurements taken at birth for HC, AC, chest circumference,
foot length and all skinfold thicknesses reached only marginal
levels of statistical significance; in all cases either the effect size
was smaller in magnitude or the underlying data had greater
variability. Ponderal index at birth was not associated with
rs9939609 genotype. In the Generation R cohort, the associa-
tion between the interaction of rs9939609 AA genotype and
maternal smoking with birth weight tended towards sig-
nificance (P5 0.075); the size and direction of effect observed
in this interaction was consistent with that seen in the Raine
cohort. A similar effect was observed for the rs9939609 TA
genotype in the Raine cohort, but this was not consistently
replicated in the Generation R cohort.
Postnatal growth
Table 3 and Fig. 2 display the abridged results of the analysis
of proportional change in weight from birth to 1 year of age.
The loss of restriction from the intrauterine environment had
a marked effect on growth. A trend was observed over the first
year of life in infants with the rs9939609 AA genotype;
proportional change in weight was greatest in those infants
from non-smoking mothers. A similar effect was not observed
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in proportional change in height over the first year. A similar
effect was observed for the rs9939609 TA genotype in the
Raine cohort, but this was not consistently replicated in the
Generation R cohort.
No association was detected, in either males or females,
between rs9939609 and either frequency or duration of
exercise in the Raine cohort at 14 years of age. The rs9939609
obesity-risk allele (A) was associated with lower fat intake in
Table 1. Obstetric, maternal and paternal characteristics in the Raine and Generation R cohorts
Raine cohort child rs9939609 genotype Generation R cohort child rs9939609 genotype
Variable
TT
(n5 396)
TA
(n5 521)
AA
(n5 162) P-valuec
TT
(n5 1284)
TA
(n5 1686)
AA
(n5 542) P-valuea
Sex
Male, n (%) 196 (49) 278 (53) 91 (56) 0.029 651 (51) 832 (49) 284 (52) 0.438
Female, n (%) 200 (51) 243 (47) 71 (44) 633 (49) 854 (51) 258 (48)
Gestational age at birth (days)
Mean (S.D.) 274 (14.3) 276 (13.6) 275 (16.3) 0.087 280 (10.9) 281 (10.2) 280 (9.8) 0.440
Missing 0 0 0 0 0 0
Pre-term birth
, 37 weeks 40 (10) 40 (8) 9 (6) 0.176 41 (3) 40 (2) 16 (3) 0.384
>37 weeks 356 (90) 481 (92) 153 (94) 1243 (97) 1646 (98) 526 (97)
Missing 0 0 0 0 0 0
Placental weight (g)
Mean (S.D.) 591 (124) 599 (124) 599 (134) 0.670 636 (142) 643 (142) 633 (137) 0.884
Missing 13 14 5 296 378 144
Placental function
Normal, n (%) 167 (42) 234 (45) 69 (43) 0.709
Impaired, n (%) 30 (8) 39 (7) 9 (6) NA NA NA –
Missing (%) 199 (50) 248 (48) 84 (52)
Maternal age (years)
Mean (S.D.) 28 (6.0) 28 (5.9) 28 (5.8) 0.985 31 (4.7) 31 (4.9) 30 (4.8) 0.295
>35 years (%) 64 (16) 80 (15) 31 (19) 0.522 209 (16) 296 (18) 89 (16) 0.619
Missing 0 0 0 0 0 0
Paternal age (years)
Mean (S.D.) 30 (6.4) 31 (6.8) 31 (7.1) 0.653 33 (5.2) 33 (5.4) 33 (5.3) 0.281
Missing 2 3 0 152 265 85
Maternal BMI (kg/m2)
Mean (S.D.)b 22.4 (4.0) 22.6 (4.6) 22.6 (4.3) 0.875 22.9 (3.5) 23.1 (3.9) 23.1 (3.6) 0.283
Missing 3 0 1 167 323 110
Paternal BMI (kg/m2)
Mean (S.D.)b 24.2 (3.1) 24.7 (3.3) 25.5 (3.5) 0.001 25.0 (3.4) 25.3 (3.4) 25.2 (3.4) 0.059
Missing 52 88 31 155 268 87
Parityc
0 195 (49) 227 (44) 79 (49) 772 (60) 985 (59) 300 (56)
1 116 (29) 170 (33) 44 (27) 393 (31) 502 (30) 177 (33)
2 63 (16) 79 (15) 25 (15) 95 (7) 147 (9) 48 (9)
3 17 (4) 32 (6) 14 (9) 18 (1) 25 (2) 9 (2)
41 5 (1) 13 (2) 0 (0) 0.130 6 (0) 3 (0) 2 (0) 0.726
Missing 0 0 0 0 24 6
Maternal smoking
No, n (%) 282 (71) 387 (74) 129 (80) 981 (82) 1177 (83) 397 (87)
Yes, n (%) 114 (29) 134 (26) 33 (20) 0.119 211 (18) 250 (17) 61 (13) 0.078
Missing 0 0 0 92 259 84
BMI, body mass index; NA, not available.
a Univariate analysis of variance or Chi-square.
bMaternal/paternal weight pre-pregnancy recalled at 18 weeks gestation. BMI derived from recalled weight.
c Parity assessed at time of recruitment (pregnancy).
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males (P5 0.012) and females (P5 0.032). Lower protein
(P5 0.039) and carbohydrate intake (P5 0.015) was also
associated with the rs9939609 obesity-risk allele (A) in males,
and a similar trend was observed in females. However, in
males, fat intake was positively correlated with exercise, sug-
gesting that these covariates are confounded, a relationship
that was not mirrored in the females. The cross-sectional
analysis of BMI at 14 years of age in the Raine cohort indi-
cated that the A allele of rs9939609 was associated with
increased BMI-adjusted-for-age, although the effect was only
detected in males (likelihood ratio test: P5 0.00009 in males
and P5 0.542 in females; Fig. 3 and Supplemental Appen-
dix). A similar effect was observed for the rs9939609 TA
genotype in the Raine cohort
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Fig. 1. (a) Longitudinal association of rs9939609 genotype (codominant model) and maternal smoking with foetal growth in the Raine
cohort. (b) Cross-sectional association of rs9939609 genotype (codominant model) and maternal smoking with birth weight in the Raine
(left) and Generation R (right) cohorts.
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Maternal pregnancy weight gain
Maternal pregnancy weight gain between gestation weeks 16
and 34 was associated with the interaction between foetal
FTO genotype and maternal smoking during pregnancy
(P5 0.01; Table 4). With respect to non-smoking mothers,
those with AA genotype foetuses had less weight gain than
those with TT genotype foetuses between 16 and 34 weeks of
gestation (8.7 v. 9.4 kg). Conversely for smoking mothers,
those with AA genotype foetuses had more weight gain than
those with TT genotype foetuses between 16 and 34 weeks of
gestation (8.8 v. 8.1 kg). This pattern of maternal pregnancy
weight gain matched the pattern of average birth weight and
was independent of placental weight.
Socioeconomic factors, including family income, maternal
education and job type, were explored in sensitivity analyses
to investigate potential confounders in all antenatal, birth and
postnatal analyses. There was no evidence of an independent
Table 2. Abridged results: cross-sectional analyses of association between rs9939609 and birth anthropometry in the Raine and Generation R Cohorts
Birth weight (g)
Raine Generation R
Mixed effects model term (coefficient) Coefficient 95% CI P-value Coefficient 95% CI P-value
Maternal smoking
Non-smoker Reference Reference Reference Reference Reference Reference
Smoker 2261 2331, 2191 4.33 10213 291 2123, 258 6.2643 1028
rs9939609 genotype
TT Reference Reference Reference Reference Reference Reference
TA 259 2108, 210 0.019 9 254, 72 0.780
AA 274 2140, 28 0.028 289 2182, 4 0.060
TT: smoker Reference Reference Reference Reference Reference Reference
TA: smoker 155 62, 249 0.001 212 257, 32 0.588
AA: smoker 150 8, 292 0.038 61 26, 129 0.075
CI, confidence interval; NS, no significant (P. 0.05) association between covariate and birth weight.
Analyses adjusted for parity from time of recruitment, foetal sex and centred gestational age and placental weight. Adjusted R2: Raine: 0.701;
Generation R: 0.560.
Table 3. Abridged results: cross-sectional analyses of association between rs9939609 and growth over the first year in the Raine and Generation
R cohorts
loge (proportional weight change in first year)
Raine Generation R
Mixed effects model term (coefficient) Coefficient 95% CI P-value Coefficient 95% CI P-value
Maternal smoking
Non-smoker Reference Reference Reference Reference Reference Reference
Smoker 0.106 0.063, 0.150 1.73 1026 0.039 0.019, 0.060 2.0133 1024
rs9939609 genotype
TT Reference Reference Reference Reference Reference Reference
TA 0.023 20.006, 0.053 0.123 20.021 20.062, 0.020 0.319
AA 0.019 20.023, 0.060 0.371 0.043 20.017, 0.102 0.157
TT: smoker Reference Reference Reference Reference Reference Reference
TA: smoker 20.079 20.137, 20.020 0.009 0.011 20.019, 0.041 0.459
AA: smoker 20.077 20.165, 0.010 0.083 20.045 20.090, 20.000 0.048
CI, confidence interval; NS, no significant (P. 0.05) association between covariate and postnatal weight change 0–1 year.
Analyses adjusted for parity from time of recruitment, foetal sex, duration of breast feeding, pregnancy diabetes and centred gestational age
and placental weight. Adjusted R2: Raine postnatal weight change 0–1year: 0.488, Generation R postnatal weight change 0–1 year: 0.364.
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association between socioeconomic factors and foetal growth
trajectories or birth anthropometry or postnatal BMI-adjusted-
for-age. Further details of the statistical analyses are available by
contacting the authors.
Discussion
Consistent with the findings of a number of previous
GWAS6,8,9 and a growing number of case–control studies,7,28,29
we have reported associations between an FTO variant and
childhood obesity. We have also shown for the first time in
humans that the rs9939609 SNP is associated with symmetric
foetal growth restriction and significantly interacts with
maternal smoking during pregnancy.
In the offspring of non-smoking mothers, the AA genotype
was associated with symmetric growth restriction in utero
from 28-week gestation that progressively accumulated
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Table 4. Association between rs9939609 and maternal weight gain
between 16 and 34 weeks of gestation stratified by maternal smoking
status: Raine cohort
Foetal FTO genotype AA TA TT
Maternal non-smokers
Mean (S.D.) (kg) 8.7 (3.6) 8.9 (3.6) 9.4 (3.7)
Min, max (kg) 22.5, 19.9 22.0, 26.0 0.0, 24.6
n 129 387 282
Missing 4 21 12
Maternal smokers
Mean (S.D.) (kg) 8.8 (2.8) 8.5 (3.8) 8.1 (4.4)
Min, max (kg) 4.0, 14.0 20.6, 22.8 220.9, 18.0
n 33 134 114
Missing 2 3 7
FTO, fat mass and obesity-associated.
Analysis of foetal FTO genotype by maternal smoking status
P-value5 0.01.
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throughout the third trimester. By 38-week gestation, the AA
genotype was associated with an HC 11 percentile points
smaller, an AC that was 15 percentile points smaller and an
FL that was 8 percentile points smaller than the TT genotype
on clinical percentile charts. Although the effects of the single
base-pair change in the FTO gene are relatively small during
foetal growth (274 g in birth weight for offspring from
non-smoking mothers), this effect equates to one third of the
well-established effect of maternal smoking on birth weight
(approximately 210 g/cigarette per day or an average of
2261 g in birth weight in the Raine cohort). There was a
consistent reduction in foetal HC, AC, FL and EFW trajec-
tories and postnatal birth weight, birth length, HC, AC, chest
circumference, foot length, triceps, parascapular and infra-
scapular skinfold thickness associated with the rs9939609
AA genotype. These data suggest that the AA genotype is
associated with symmetric growth restriction in early life, as
no relationship was demonstrated with in utero HC/AC ratio
or postnatal ponderal index. Similar effects on foetal growth
were often, although not consistently, observed for the
rs9939609 TA genotype, supporting the possibility that the
effect may be additive and dependent upon the number of A
obesity-risk alleles that an individual carries. Previous studies
have failed to demonstrate a relationship between FTO
genetic variants and birth weight or birth anthropometry.6,14
However, these studies did not examine possible interactions
with smoking or adjust for GA at birth. There is a universal
agreement that maternal smoking is associated with a
reduction in birth weight of approximately 175–200 g with a
consistent and dose–dependent negative effect of smoking on
birth weight.30 Since the original report in 195731 of the
association between maternal smoking during pregnancy and
reduced birth weight, this observation has been replicated in
more than 100 published studies, which have included eva-
luation of more than 500,000 births.32 The positive findings
in our study suggest that consideration of the effects of
maternal smoking during pregnancy may be crucial when
attempting to uncover modest genetic effects on foetal growth
and birth weight. The findings also highlight the importance
of accurate and objective assessment of GA and growth in
utero by ultrasonography.
A key question that arises from our findings is why does
FTO have opposite effects on intrauterine and postnatal
growth? Common variants in the first intron of FTO have
been consistently associated with obesity and with increased
BMI and fat, but not with lean mass.6 Further, the rs9939609
at-risk A allele has been shown to be associated with increased
resting and total energy expenditure, increased energy intake,
hyperphagia with a preference for energy rich foods and
diminished satiety.10,12,33 Moreover, it has recently been
shown that inactivation of the FTO gene in an FTO-deficient
mouse has no effect on birth weight; however, results in
postnatal growth retardation and a significant reduction in
adipose tissue and lean body mass.34 The expression of FTO
has been shown to be influenced by nutrition with expression
in the hypothalamus reduced by 60% in fasting mice and not
rescued by leptin supplementation.34 Further, in a large
population of predominantly lean Gambians, living a tradi-
tional lifestyle in an environment where little excess food is
available, FTO genotype did not influence measures of body
mass, or had a smaller effect than detected in Europeans.35
Foetal nutrition is not exclusive, but closely related, to
maternal nutrition given that the foetus is at the end of a
nutritional supply chain. Both placental FTO genotype and
FTO expression may also influence foetal weight. In both the
cohorts in this study, there was no detectable association
between rs9939609 genotype and placental weight (see Table 1;
P5 0.670 and P5 0.884), suggesting that the association of
FTO rs9939609 genotype with birth weight is independent
of placental weight. These results are consistent with those
recently published in a study by Bassols et al.,36 who reported
that placental FTO expression and foetal FTO rs9939609
genotype was not associated with placental weight. Taken
together, these data suggest that the association between
rs9939609 genotype and birth weight relates to nutrient
supply or placental transfer of nutrients. This hypothesis is
supported by data from the Raine cohort where non-smoking
mothers of AA genotype foetuses had less pregnancy weight
gain than non-smoking mothers of TT genotype foetuses
between 16 and 34 weeks of gestation (8.7 v. 9.4 kg; Table 4).
These data provide some evidence to suggest that there
may be less nutrients available to the AA genotype foetuses of
non-smoking mothers than the TT genotype foetuses, with
concomitant reduced birth weight but no corresponding
difference in placental size.
The association between the FTO risk allele and foetal
growth restriction suggest reduced expression of FTO in utero.
This may be because the foetal hypothalamus perceives
‘reduced nutrition in utero’. The sequence of FTO is highly
conserved from humans to algae and encodes a 2-oxoglutarate
(2-OG) dependent nucleic acid demethylase.37 2-OG oxy-
genases are involved in diverse processes, including DNA
repair, fatty acid metabolism and post translational mod-
ifications including proline hydroxylation and histone lysine
demethylation.38,39 They require non-heme iron [Fe(II)] as a
cofactor, use oxygen and, almost always, 2OG as co-substrates.37
The hypoxic intrauterine environment (pO2 18–44mmHg) is
likely to be associated with reduced expression or function of
FTO in utero as 2-OG oxygenases utilise oxygen as a substrate. In
addition, the primary effect of FTO appears to be through
hyperphagia and in utero the foetus has limited abilities to reg-
ulate its nutritional supply. These factors may result in a similar
foetal growth pattern to that seen in the FTO-deficient mouse
during the postnatal period. However, once birth occurs, the
neonate and child are normoxic and can regulate (to some extent)
their own nutrition. Children can thus increase their energy
intake, partly through poor food choices33 and exposure to an
obesogenic environment, which may result in obesity as early as
8 years of age as seen in the Raine cohort. We have presented
some data to support this postulate with the AA genotype in
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infants from non-smoking mothers demonstrating the highest
proportional growth during the first year of life (Fig. 2).
An alternative hypothesis to explain our findings relates to
the maternal genotype. For a foetus to be homozygous for the
at-risk allele, the mother must be either homozygous or
heterozygous for the same allele. Given the potential role of
FTO in controlling food intake and lipid metabolism, it
would be expected that during pregnancy mothers who are
homozygous or heterozygous for the at-risk allele conserve
their energy to lay down fat (at the expense of the foetus),
resulting in reduced nutrient supply for the foetus and growth
restriction. This hypothesis was not supported by the
maternal pregnancy weight gain results in either non-smoking
or smoking mothers. Further research is required to elucidate
why non-smoking mothers have an inverse relationship
between the foetal rs9939609 A allele (a surrogate for
maternal rs9939609 A allele) and energy intake.
Twin studies have shown that the heritability of BMI
increases across early-to-middle childhood, an effect that is
mirrored in the strengthening association between the FTO
rs9939609 genotype and BMI across childhood. These
observations may be explained by the increasing expression of
FTO across childhood or the self-selection of environments
correlated with genetic propensities, such as increased fre-
quency and opportunities to overeat.6,12 The FTO rs9939609
genotype in children was associated with pre-pregnancy
paternal BMI in the Raine and Generation R studies. The
lack of association between the FTO rs9939609 genotype and
pre-pregnancy maternal BMI may reflect reporting or recall
bias. However, women may lose weight before pregnancy if
they are overweight or have issues with fertility.
The observation that maternal smoking interacts with the
FTO risk allele to reverse the effects of foetal growth was an
unexpected finding. This observation requires further repli-
cation and evaluation to uncover the mechanisms responsible
for this finding. We have postulated a number of potential
mechanisms to explain this observation. In the Raine cohort,
we have demonstrated that the patterns of maternal weight
gain in pregnancy are different in smokers and non-smokers
with smokers having less weight gain between 16 and 34
weeks than non-smokers (8.4 v. 9.0 kg; Table 4). These
results are consistent with previous publications, suggesting
that smokers have suppressed appetite.40 Moreover, maternal
weight gain in pregnancy is associated with foetal FTO
rs9939609 genotype, with a reversal of the effect in smokers
to that seen in non-smokers. With respect to non-smoking
mothers, those with AA genotype foetuses had less weight
gain than mothers of TT genotype foetuses between 16 and
34 weeks of gestation (8.7 v. 9.4 kg; Table 4). Conversely, for
smoking mothers, those with AA genotype foetuses had more
weight gain than mothers of TT genotype foetuses between
16 and 34 weeks of gestation (8.8 v. 8.1 kg; Table 4). These
data suggest that smoking mothers of AA genotype foetuses
had similar weight gain between 16 and 34 weeks of gestation
compared with non-smoking mothers of AA genotype foetuses;
the similar maternal nutrient supply was reflected in similar
birth weights. The smoking mothers of the TT genotype
foetuses had the least weight gain between 16 and 34 weeks of
gestation (8.2 kg) of all maternal smoking-foetal genotype
combinations. This was reflected in this group also having the
lowest average birth weight. Taken together these data suggest
that a potential mechanism through which maternal smoking
may interact with the foetal FTO risk allele may be through
maternal nutrition and its subsequent effects on the maternal
nutrition supply chain to the foetus. This hypothesis requires
further exploration, such as investigating the association of
maternal rs9939609 genotype with maternal weight gain
during pregnancy in smokers and non-smokers. Similarly,
further exploration is required to determine whether foetal
FTO expression is involved in the regulation of maternal
metabolism and energy intake and whether maternal smoking
disrupts related signalling pathways. We do not rule out that
the interaction between FTO genotype and maternal smoking
may be because of one or more of the approximate 1000
compounds present in cigarette smoke.
The consistent size and direction of the interaction between
the rs9939609 SNP and maternal smoking seen in Genera-
tion R is reassuring (Table 2). Interestingly, the biggest effect
of the interaction between rs9939609 genotype and maternal
smoking on foetal growth was seen in smoking mothers,
where the foetal TT genotype was associated with a 261 g
reduction in birth weight compared with the TT genotype
foetuses of non-smoking mothers. In European populations
such as the Raine or Generation R cohorts, 20 cigarettes per
day results in a reduction in birth weight of approximately
250 g. In Chinese–Asian populations, where the T-allele is at
a much higher prevalence,27 a mean of nine cigarettes per day
results in a reduction in birth weight of 200 g, almost double
the effect size seen in European populations.41 The mechanisms
responsible for the greater impact of maternal smoking on foetal
growth in Asian populations are unknown; however, gene3
environment interactions such as those demonstrated in this
study with FTO require evaluation in future studies across
different ethnic populations. Polymorphisms in other genes
such as the metabolic genes CYP1A1 (cytochrome P450
family 1, subfamily A, polypeptide 1), GSTT1 (glutathione
S-transferase Theta-1) and GSTM1 (glutathione S-transferase
Mu-1) also require further evaluation after the recent publica-
tion of interactions between maternal genotype and foetal
growth with these specific variants, increasing the odds of foetal
growth restriction in smokers 1.5- to 1.9-fold.42 These three
genes are thought to influence an individual’s susceptibility to
carcinogens and toxins and may have an important role in the
adverse health effects of cigarette smoking.43–46
At 14 years of age, in male offspring, BMI is indepen-
dently, positively associated with maternal smoking during
pregnancy, birth weight, change in weight during the first
year of life and protein intake at age 14 years and is negatively
associated with duration of breast feeding and current car-
bohydrate and fat intake. Despite the males exercising, on
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average, more often and for longer than females, exercise
frequency and duration were not independently associated
with BMI at 14 years of age. In males, both the TA and AA
rs9939609 genotypes were associated with increased BMI at
14 years of age, and there was limited evidence of a protective
effect of increased duration of exercise in individuals with
these genotypes. In addition, the increased birth weight,
observed in the offspring of smokers with the rs9939609 AA
and TA genotypes, contributed to increased fat mass in
adolescence, although this effect was only partially offset by a
smaller weight gain over the first year of life in these indivi-
duals. This would suggest that obesity prevention pro-
grammes for males may benefit from a focus on increased
exercise rather than reduced dietary intake during adoles-
cence, in addition to the prevention of maternal smoking
during pregnancy. In contrast, in female adolescents, only
birth weight and change in weight during the first year of life
are independently, positively associated with BMI. These
results provide limited insight into the formation of obesity
prevention programmes in females.
Foetal growth is a complex trait associated with potentially
hundreds of genetic variants, across a range of functional
pathways, each conferring a small effect on foetal growth.
Cumulatively, the effect of multiple genetic variants may
produce clinically relevant differences in growth. The detection
of new genetic variants associated with foetal growth has the
potential to identify novel molecular mechanisms underlying
growth and can yield insights of biological importance. The
important challenge over the next decade is the identification of
critical windows for intervention to influence the progressive
increase in prevalence of childhood and adult obesity and related
diseases such as type-2 diabetes. Characteristisation of the
interactions between genes and the environment, which are
related to foetal and postnatal growth, may pave the way for
more sensitive analysis of the early childhood environment
and may allow better targeting of future interventions and
health promotion.
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